Compliance with a three-day course of artesunate-mefloquine combination and baseline anti-malarial treatment in an area of Thailand with highly multidrug resistant falciparum malaria

[11] Luxemburger C(2003)Investigation of bioavailability, pharmacokinetics and safety of new pediatric formulations of artesunate and mefloquine Am J Trop Med Hyg 68 620-222

[12] Thway KL(2009)Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development Fundam Clin Pharmacol 23 387-346

[13] Brockman A(1989)The efficacy of combined mefloquine-artesunate Southeast Asian J Trop Med Public Health 20 55-338

[14] McGready R(1994) mefloquine-primaquine on subsequent development of Trans R Soc Trop Med Hyg 88 220-2285

[15] ter Kuile F(1999) gametocytemia Antimicrob Agents Chemother 43 341-279

[16] Looareesuwan S(2002)Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development Br J Clin Pharmacol 53 337-1310

[17] White NJ(2006)Determination of mefloquine in biological fluids using high performance liquid chromatography Antimicrob Agents Chemother 50 2281-725

[18] Muheki C(1990)Pharmacokinetics of primaquine in G6PD deficient and G6PD normal patients with vivax malaria Clin Pharmacokinet 19 264-33

[19] McIntyre D(2001)Pharmacokinetics of mefloquine combined with artesunate in children with acute falciparum malaria Clin Ther 23 1296-642

[20] Barnes KI(1996)The influence of body weight on the pharmacokinetics of mefloquine Am J Hypertens 9 719-73

[11] Luxemburger C(2003)Investigation of bioavailability, pharmacokinetics and safety of new pediatric formulations of artesunate and mefloquine Am J Trop Med Hyg 68 620-222

[12] Thway KL(2009)Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development Fundam Clin Pharmacol 23 387-346

[13] Brockman A(1989)The efficacy of combined mefloquine-artesunate Southeast Asian J Trop Med Public Health 20 55-338

[14] McGready R(1994) mefloquine-primaquine on subsequent development of Trans R Soc Trop Med Hyg 88 220-2285

[15] ter Kuile F(1999) gametocytemia Antimicrob Agents Chemother 43 341-279

[16] Looareesuwan S(2002)Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development Br J Clin Pharmacol 53 337-1310

[17] White NJ(2006)Determination of mefloquine in biological fluids using high performance liquid chromatography Antimicrob Agents Chemother 50 2281-725

[18] Muheki C(1990)Pharmacokinetics of primaquine in G6PD deficient and G6PD normal patients with vivax malaria Clin Pharmacokinet 19 264-33

[19] McIntyre D(2001)Pharmacokinetics of mefloquine combined with artesunate in children with acute falciparum malaria Clin Ther 23 1296-642

[20] Barnes KI(1996)The influence of body weight on the pharmacokinetics of mefloquine Am J Hypertens 9 719-73